Efficacy and tolerability of eslicarbazepine acetate as monotherapy in patients of newly diagnosed focal epilepsy

INTRODUCTION: Eslicarbazepine Acetate, a novel anti-epileptic drug has been approved as monotherapy in focal onset seizures, with/without secondary generalization in adults. Eslicarbazepine has many advantages over older anti-epileptic drugs and is useful in patients of new onset focal epilepsy. OBJ...

Descripción completa

Detalles Bibliográficos
Autores principales: Saxena, S., Singh, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2021
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9480346/
http://dx.doi.org/10.1192/j.eurpsy.2021.2049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9480346/
http://dx.doi.org/10.1192/j.eurpsy.2021.2049

Ejemplares similares